14080 Federal Register / Vol. 89, No. 38 / Monday, February 26, 2024 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines Meeting; Correction 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice; correction. 

SUMMARY: HRSA published a notice in 

the Federal Register on February 2, 

2024, concerning 2024 calendar year 

meetings of the Advisory Commission 

on Childhood Vaccines (ACCV). The 

notice contained incorrect dates. The 

notice originally stated the 2024 

calendar year meetings will take place 

in ‘‘2023’’ and the meeting dates are 

being updated to say ‘‘2024.’’ 

FOR FURTHER INFORMATION CONTACT: Pita 

Gomez, Principal Staff Liaison, Division 

of Injury Compensation Programs, 

HRSA, 5600 Fishers Lane, 8W–25A, 

Rockville, Maryland, 20857; 800–338– 

2382; or ACCV@hrsa.gov 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of February 2, 

2024, FR Doc. 2024–02106, page 7400, 

column 2, correct the DATES caption to 

read: ‘‘The ACCV meetings will be held 

on: 

• March 7, 2024, 1 p.m. eastern time 

(ET)–4 p.m. ET; 

• March 8, 2024, 1 p.m. ET–4 p.m. 

ET; 

• September 5, 2024, 1 p.m. ET–4 

p.m. ET; 

• September 6, 2024, 1 p.m. ET–4 

p.m. ET.’’ 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–03824 Filed 2–23–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the National Advisory 

Committee on Rural Health and Human 

Services 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the Secretary’s 

National Advisory Committee on Rural 

Health and Human Services 

(NACRHHS) has scheduled a public 

meeting. Information about NACRHHS 

and the agenda for this meeting can be 

found on the NACRHHS website at: 

https://www.hrsa.gov/advisorycommittees/rural-health/index.html. 

DATES: Tuesday, April 9, 2024, 9 a.m.– 

5 p.m. central time (CT); Wednesday, 

April 10, 2024, 9 a.m.–5 p.m. CT; 

Thursday, April 11, 2024, 9 a.m.–12 

p.m. CT. 

ADDRESSES: This meeting will be held at 

the Hyatt House, 901 Neches Street, 

Austin, Texas 78701. The meeting will 

also be accessible to the public via 

Zoom. Please use the following 

information to join the meeting: https:// 

us02web.zoom.us/j/83119377601. 

Or One tap mobile: 

+13052241968,,83119377601# U.S. 

+19294362866,,83119377601# U.S. 

(New York) 

Or Telephone: 

Dial (for higher quality, dial a number 

based on your current location): 

+1 305 224 1968 U.S. 

+1 929 436 2866 U.S. (New York) 

+1 301 715 8592 U.S. (Washington, DC) 

+1 312 626 6799 U.S. (Chicago) 

+1 669 900 6833 U.S. (San Jose) 

+1 253 215 8782 U.S. (Tacoma) 

+1 346 248 7799 U.S. (Houston) 

Webinar ID: 831 1937 7601 

International numbers available: 

https://us02web.zoom.us/u/kwqsKE6sY. 

FOR FURTHER INFORMATION CONTACT: 

Sahira Rafiullah, Executive Secretary of 

NACRHHS, 5600 Fishers Lane, 

Rockville, Maryland 20857; 240–316– 

5874; or srafiullah@hrsa.gov. 

SUPPLEMENTARY INFORMATION: 

NACRHHS provides advice and 

recommendations to the Secretary of 

Health and Human Services on policy, 

program development, and other 

matters of significance concerning both 

rural health and rural human services. 

At this meeting, NACRHHS will discuss 

two topics: technology and innovation 

in rural health and quality reporting by 

rural health clinics. Members of the 

public will have the opportunity to 

provide comments. 

Public participants wishing to provide 

oral comments must submit a written 

version of their statement at least 3 

business days in advance of the 

scheduled meeting. Oral comments will 

be honored in the order they are 

requested and may be limited as time 

permits. Public participants wishing to 

offer a written statement should send it 

to Sahira Rafiullah, using the contact 

information above, at least 3 business 

days prior to the meeting. Individuals 

who plan to attend in person and need 

special assistance or another reasonable 

accommodation should notify Sahira 

Rafiullah at the address and phone 

number listed above at least 10 business 

days prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–03823 Filed 2–23–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; ADRD Initiative. 

Date: March 19, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: Mirela Milescu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH/HHS, NSC, 6001 Executive 

Blvd., Rockville, MD 20852, mirela.milescu@

nih.gov, 301–496–5720. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; P01 Review. 

Date: March 21–22, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: Li Jia, Ph.D., Scientific 

Review Officer, Scientific Review Branch, 

Division of Extramural Activities, NINDS/ 

NIH/HHS, NSC, 6001 Executive Blvd., 

Rockville, MD 20852, 301–451–2854, li.jia@

nih.gov. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 38 / Monday, February 26, 2024 / Notices 14081 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS.) 

Dated: February 20, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–03818 Filed 2–23–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; AIDS and 

Cancer Specimen Resource-UM1. 

Date: March 20, 2024. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W126, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Mukesh Kumar, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W126, 

Rockville, Maryland 20850, 240–276–6611, 

mukesh.kumar3@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 21, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–03840 Filed 2–23–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Endocrinology, Metabolism and 

Reproduction. 

Date: March 7–8, 2024. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Dianne Hardy, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6175, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1154, dianne.hardy@nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Aging, Injury, Musculoskeletal, and 

Rheumatologic Disorders Study Section. 

Date: March 14–15, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nketi I. Forbang, MD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1006K1, 

Bethesda, MD 20892, (301) 594–0357, 

forbangni@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: March 14–15, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Reigh-Yi Lin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 4152, 

MSC 7846, Bethesda, MD 20892, (301) 827– 

6009, lin.reigh-yi@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; BRAIN 

Initiative: Targeted BRAIN Circuits Projects. 

Date: March 14–15, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jonathan Arias, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892, (301) 435– 

2406, ariasj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Understanding pathogenesis and 

pathophysiology of neurodegenerative 

diseases. 

Date: March 14, 2024. 

Time: 1:30 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Wei-Qin Zhao, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5181, 

MSC 7846, Bethesda, MD 20892–7846, 301– 

827–7238, zhaow@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Endocrine and Metabolism Study 

Section. 

Date: March 14, 2024. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Heather Marie Brockway, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 813H, 

Bethesda, MD 20892, (301) 594–5228, 

brockwayhm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–RM– 

23–018: Community Partnerships to Advance 

Science for Society (ComPASS): Health 

Equity Research Hubs. 

Date: March 15, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maria De Jesus Diaz Perez, 

Ph.D., Scientific Review Officer, Center for 


khammond on DSKJM1Z7X2PROD with NOTICES